Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | CYCN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,83 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 1,7501 - 6,75 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 2,83 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
7,67M | 2,71M | - | 0 | -5,26M | -1,94 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Cyclerion Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
26/1/2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
11/12/2023 | 23:09 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
04/12/2023 | 23:09 | Edgar (US Regulatory) | Form 8-K - Current report |
04/12/2023 | 14:00 | GlobeNewswire Inc. | Cyclerion Appoints Regina Graul, Ph.D., as President |
01/12/2023 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
01/12/2023 | 00:16 | GlobeNewswire Inc. | Cyclerion Strengthens Board of Directors with Experienced.. |
24/11/2023 | 19:06 | Edgar (US Regulatory) | Form 8-K - Current report |
13/11/2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/10/2023 | 22:58 | Edgar (US Regulatory) | Form 8-K - Current report |
31/7/2023 | 13:00 | GlobeNewswire Inc. | Tisento Launches with $81 Million From Top-Tier Investor.. |
28/7/2023 | 22:48 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
19/7/2023 | 23:27 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Cyclerion Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Cyclerion Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 2,79 | 3,1906 | 2,77 | 2,93 | 931 | 0,04 | 1,43% |
1 mois | 3,41 | 3,98 | 2,77 | 3,16 | 3 157 | -0,58 | -17,01% |
3 mois | 2,99 | 4,00 | 2,70 | 3,17 | 2 850 | -0,16 | -5,35% |
6 mois | 2,51 | 5,25 | 1,7501 | 3,23 | 5 368 | 0,32 | 12,75% |
1 an | 5,33 | 6,75 | 1,7501 | 4,58 | 21 753 | -2,50 | -46,90% |
3 ans | 43,60 | 97,20 | 1,7501 | 47,53 | 276 719 | -40,77 | -93,51% |
5 ans | 306,40 | 349,20 | 1,7501 | 66,52 | 342 492 | -303,57 | -99,08% |